Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Phylogica
Phylogica
Activities:
Ingredients
Research & Development
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Phylogica signs deal with UK biotech to identify and develop cancer drugs
Takes a 7.5% stake in PhoreMost, based in Cambridge
Research & Development
Phylogica enters into research and licensing agreement with Genentech
Perth, Australia-based company will receive an upfront payment of US$500,000
Research & Development
Phylogica expands peptide drug conjugates pact with Janssen
Australian firm has received an undisclosed payment to fund additional research
Research & Development
Phylogica enters peptide agreement with Janssen Biotech
To identify cell-penetrating Phylomer peptides
Research & Development
Phylogica forms target discovery spin-off
Sets up new venture called Phenomica with University of Cambridge in the UK
Research & Development
Phylogica completes first stage of collaboration with Roche
Receives undisclosed milestone payment
Research & Development
Phylogica to collaborate with Pfizer
To discover novel peptide-based vaccines
Subscribe now